CC - The Chemours Company

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue6,183,0005,400,0005,717,0006,432,000
Cost of Revenue4,429,0004,290,0004,762,0005,072,000
Gross Profit1,754,0001,110,000955,0001,360,000
Operating Expenses
Research Development80,00080,00097,000143,000
Selling General and Administrative602,000599,000632,000685,000
Non Recurring----
Others----
Total Operating Expenses5,111,0004,969,0005,491,0005,900,000
Operating Income or Loss1,072,000431,000226,000532,000
Income from Continuing Operations
Total Other Income/Expenses Net-160,000-442,000-414,00018,000
Earnings Before Interest and Taxes1,072,000431,000226,000532,000
Interest Expense-215,000-223,000-132,000-132,000
Income Before Tax912,000-11,000-188,000550,000
Income Tax Expense165,000-18,000-98,000149,000
Minority Interest5,0004,0004,0004,000
Net Income From Continuing Ops747,0007,000-90,000401,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income746,0007,000-90,000400,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares746,0007,000-90,000400,000